Significant SEND
Contract Expansion

A global provider of leading software solutions
and services to the life sciences community.

Helping our clients bring life enhancing products to market faster.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.


Latest News

02 October 2018 - Exercise of Options and Total Voting Rights

Read More

24 September 2018 - Half Year Report

Read More

10 September 2018 - Notice of Results

Read More

Annual Report 2017

Strong margins and cash performance

Annual Report 2017

We have maintained our pre-eminent position in the preclinical market and taken further market share in the now FDA mandated SEND market.

Strong margins and cash performance

Regulatory Solutions business continues to deliver
Research Note by Gareth Evans of Progressive Equity Research